News | News By Subject | News by Disease News By Date | Search News

Migraine News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Allergan (AGN) Looks to Expand Beyond Botox with Oral Migraine Treatments     10/12/2016
Cambridge's CoLucid Pharma (CLCD) Rockets on Late-Stage Migraine Data     9/7/2016
Amgen (AMGN) Shows Off Mid-Stage Migraine Data, Needs to Compete With Eli Lilly (LLY), Teva (TEVA) and Alder Biopharma     6/9/2016
Alder Biopharma's Migraine Drug Meets Primary and Secondary Endpoints in Phase 2b Trial     3/28/2016
Tonix Pharma (TNXP) Craters as Headache Drug Flunks Phase II Study     2/16/2016
FDA Approves AVANIR (AVNR) New Migraine Treatment With Unique Inhalant Delivery System     2/1/2016
Heptares Lines Up a $410 Million Migraine Pact with Teva (TEVA)     11/25/2015
Allergan (AGN) Slams Down $250 Million+ for Rights to Merck & Co. (MRK)'s Migraine Drugs     7/7/2015
Amgen (AMGN)'s Migraine Drug Meets Goals in Phase II Study     5/19/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AVANIR Pharmaceuticals (AVNR)'s Migraine Treatment Will Unlikely Win Approval By Scheduled Timeline     11/7/2014
AVANIR Pharmaceuticals (AVNR)' Migraine Drug AVP-825 Meets Primary Endpoint in Phase 3 Trial     6/10/2014
OptiNose AS Presents Positive Results From Phase 3 COMPASS Study     6/10/2014
GlaxoSmithKline (GSK), Pernix Therapeutics, Inc. (PTX) Ink $250 Million Migraine Drug Deal     5/15/2014

News from Around the Web
Amgen (AMGN) Maintains Migraine Drug Lead     9/30/2016
The Drug Industry Might Finally Have An Answer For Migraines     9/26/2016
Does Eating More Salt Prevent Migraines And Severe Headaches? Huntington Medical Research Institutes Study     8/16/2016
Emotional Abuse In Childhood Linked To Migraines In Adulthood, Yale University Study     7/14/2016
NYU Langone Medical Center Researchers Pinpoint Best Meds To Treat Migraine In The ED     6/27/2016
Can Light Help Ease The Pain Of Migraines? Texas A&M University Study     6/23/2016
Migraines Linked To Vitamin Deficiencies, Cincinnati Children's Hospital Medical Center Says Study     6/13/2016
New Drug To Prevent Migraine May Start Working In Days, Teva (TEVA) Reveals     6/9/2016
Women With Migraines More Prone To Heart Disease And Early Death, Harvard Medical School Study     6/1/2016
Green Light For Migraine Relief, Harvard Medical School Study     5/20/2016
Botox Can Be Used For Chronic Migraine, Icahn School Of Medicine At Mount Sinai Study     4/21/2016
An App A Day To Keep The Doctor Away     3/28/2016
Do Genes Link Headaches, Irritable Bowel Syndrome? Istanbul University Study     2/24/2016
Migraine With Aura Linked To Clot-Caused Strokes, University of South Carolina Study     2/18/2016
Medical Marijuana Decreases Migraines, University of Colorado Anschutz School Of Pharmacy Study Shows     1/18/2016

Press Releases
Amgen (AMGN) and Novartis AG (NVS) Keep Lead in Migraine Drug Race on Positive Phase III Data     11/17/2016
touchNEUROLOGY.com Release: New Review Of Novel Intranasal Delivery Of Sumatriptan As A Route To Rapid And Sustained Relief In The Acute Treatment Of Migraine     11/17/2016
Migraine Breakthrough At Xi'an Jiaotong-Liverpool University Could Lead To Improved Drugs     11/16/2016
CoLucid Pharma (CLCD) Provides SPARTAN Enrollment Update     11/14/2016
Zosano (ZSAN) Announces Completion Of Enrollment In Pivotal Efficacy Trial For M207 For Acute Migraine     11/8/2016
Curelator Headache Announces Study With NYU Langone Medical Center To Examine Effectiveness Of Protective Behaviors For Migraineurs And Post-Concussive Headache Patients     10/18/2016
electroCore's Bioelectric Medicine, nVNS, Successfully Treats Menstrual Migraine     10/12/2016
Amgen (AMGN), Novartis AG (NVS)'s Migraine Drug Successful in Phase III Study     9/29/2016
Pernix (PTX) Announces Distribution Of TREXIMET 10/60 Mg (Sumatriptan 10mg And Naproxen Sodium 60 Mg) Dose For Use In Pediatric Patients     9/29/2016
Theranica Announces The Closing Of Seed Funding Round And Reports Promising Clinical Results In Acute Migraine Study Using Its Proprietary Wearable Technology     9/20/2016
Novartis AG (NVS) Says Experimental Drug Helps Chronic Migraine Sufferers     9/19/2016
CoLucid Pharma (CLCD) Provides Interim Update On GLADIATOR     9/19/2016
CoLucid Pharma (CLCD) Announces Achievement Of Secondary Endpoints In SAMURAI     9/19/2016
Amgen (AMGN) Presents Positive Data At EHMTIC 2016 Demonstrating Erenumab Significantly Reduces Monthly Migraine Days In Patients With Chronic Migraine     9/16/2016
Scientists Discover Noninvasive Technique To Monitor Migraines, University of British Columbia Study     8/31/2016

//-->